[Nitric oxide and pulmonary hypertension].
Nakamoto
Takaaki
T
Department of Cardiology and Pneumology, Dokkyo University School of Medicine.
Harasawa
Hiroshi
H
Fuse
Daisuke
D
Amano
Hirohisa
H
Matsuda
Toshiya
T
D015106:3',5'-Cyclic-GMP Phosphodiesterases; D000280:Administration, Inhalation; D000818:Animals; D001120:Arginine / Q000627:therapeutic use; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D015316:Genetic Therapy; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D000860:Hypoxia; D008833:Microcirculation; D009569:Nitric Oxide / Q000096:biosynthesis / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use; D020030:Nitric Oxide Donors / Q000627:therapeutic use; D019001:Nitric Oxide Synthase / Q000235:genetics / Q000502:physiology; D052250:Nitric Oxide Synthase Type III; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010727:Phosphoric Diester Hydrolases / Q000502:physiology; D011652:Pulmonary Circulation; D014661:Vasoconstriction
D020030:Nitric Oxide Donors; D010726:Phosphodiesterase Inhibitors; D009569:Nitric Oxide; D001120:Arginine; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D010727:Phosphoric Diester Hydrolases; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; C517381:PDE5A protein, human